Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Current Assets (2016 - 2025)

STRATA Skin Sciences' Current Assets history spans 15 years, with the latest figure at $15.6 million for Q4 2025.

  • On a quarterly basis, Current Assets fell 6.0% to $15.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.6 million, a 6.0% decrease, with the full-year FY2025 number at $15.6 million, down 6.0% from a year prior.
  • Current Assets hit $15.6 million in Q4 2025 for STRATA Skin Sciences, up from $14.3 million in the prior quarter.
  • Over the last five years, Current Assets for SSKN hit a ceiling of $24.1 million in Q1 2021 and a floor of $13.2 million in Q1 2024.
  • Historically, Current Assets has averaged $17.5 million across 5 years, with a median of $16.2 million in 2024.
  • Biggest five-year swings in Current Assets: tumbled 34.93% in 2024 and later grew 19.92% in 2025.
  • Tracing SSKN's Current Assets over 5 years: stood at $20.0 million in 2021, then decreased by 24.63% to $15.1 million in 2022, then increased by 3.26% to $15.5 million in 2023, then rose by 6.77% to $16.6 million in 2024, then fell by 6.0% to $15.6 million in 2025.
  • Business Quant data shows Current Assets for SSKN at $15.6 million in Q4 2025, $14.3 million in Q3 2025, and $13.8 million in Q2 2025.